Clinical Trial Update: Instanyl® Non-Interventional Study

View source ↗

Summary

Takeda's Instanyl (fentanyl nasal spray) non-interventional study focused on breakthrough cancer pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Instanyl (Fentanyl citrate)

Snippet

Sponsor: Takeda | Conditions: Breakthrough Cancer Pain | Status: COMPLETED